SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-006820
Filing Date
2019-08-01
Accepted
2019-08-01 16:20:05
Documents
79
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20190630x10q.htm   iXBRL 10-Q 1872724
2 EX-31.1 bpmc-20190630ex3115453b3.htm EX-31.1 18210
3 EX-31.2 bpmc-20190630ex312cd6bd8.htm EX-31.2 18242
4 EX-32.1 bpmc-20190630ex321ae56d6.htm EX-32.1 13852
  Complete submission text file 0001558370-19-006820.txt   7286776

Data Files

Seq Description Document Type Size
5 EX-101.SCH bpmc-20190630.xsd EX-101.SCH 53731
6 EX-101.CAL bpmc-20190630_cal.xml EX-101.CAL 62140
7 EX-101.DEF bpmc-20190630_def.xml EX-101.DEF 183025
8 EX-101.LAB bpmc-20190630_lab.xml EX-101.LAB 491281
9 EX-101.PRE bpmc-20190630_pre.xml EX-101.PRE 375511
10 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20190630x10q_htm.xml XML 1244646
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 19992964
SIC: 2834 Pharmaceutical Preparations